跳至主要内容
临床试验/NCT00002276
NCT00002276已完成不适用

Study of Bleeding Tendency, Platelet Function, and Pharmacokinetics of Azidothymidine (AZT) and Motrin (Ibuprofen) in HIV-Infected Hemophiliacs

University of Pittsburgh1 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
1

研究概览

简要总结

To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients must have:
  • •Hemophilia.
  • •HIV-seropositivity confirmed by Western Blot.
  • •Prior Medication:
  • •- AZT for study patients.
  • •- Ibuprofen.

排除标准

  • •Co-existing Condition:
  • •Patients with the following symptoms and conditions are excluded:
  • •Hospitalization for opportunistic infection, bacterial infection or malignancy.
  • •Concurrent Medication:
  • •AZT (for control group).
  • •Antibiotics or other medication for opportunistic infection, bacterial infection, or malignancy.
  • •Patients with the following prior conditions are excluded:
  • •Hospitalization for opportunistic infection, bacterial infection, or malignancy.
  • •Ibuprofen.
  • •AZT 1-2 gm daily (for study patient) or not taking AZT (for control).

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验